{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:38:55Z","timestamp":1788914335846,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Polycythemia vera (PV) is a myeloproliferative neoplasm driven by JAK2 mutations and associated with thrombotic complications. Current risk stratification classifies younger patients without prior thrombosis as low\u2010risk (LR), yet long\u2010term outcomes in this group remain poorly defined. In this retrospective cohort study, we used the Clalit Health Services database to identify patients aged 18\u201360\u00a0years with JAK2\u2010positive PV diagnosed between 2005 and 2022. Patients without prior or concurrent thrombosis were classified as LR. Clinical characteristics, treatments, and outcomes were analyzed. Logistic regression analysis was used to identify predictors of thrombosis. Among 505 patients, 437 (86.5%) were classified as LR. Median age was 51\u00a0years and 58.6% were male. Cytoreductive therapy was used in 61% of LR patients. Over a median follow\u2010up of 8.6\u00a0years, thrombosis occurred in 17.4% of LR patients (11.7% arterial, 5.7% venous). Cardiovascular risk factors (CV\u2010RFs) were strongly associated with thrombosis (\u2265\u00a02 CV\u2010RFs, OR\u00a0=\u00a03.10, 95% CI 1.25\u20137.72;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0=\u00a00.015), while hematologic parameters were not. Cytoreductive therapy was independently associated with a reduced risk of thrombosis. Secondary malignancies were diagnosed in 16.2%, mainly non\u2010melanoma skin cancer in 11.7%. Prior Hydroxyurea (HU) use was independently associated with secondary malignancy (OR\u00a0=\u00a02.73; 95% CI 1.33\u20135.61;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0=\u00a00.006), alongside age and leukocytosis. Disease progression to myelofibrosis, myelodysplastic syndrome, or acute myeloid leukemia occurred in 3.4%, 5.7%, and 1.6% of LR patients, respectively. HU use was associated with disease progression (OR\u00a0=\u00a02.9; 95% CI 1.33\u20136.42;\n                    <jats:italic>p<\/jats:italic>\n                    \u00a0=\u00a00.008). We concluded that despite being classified as low\u2010risk, younger patients with PV experience a substantial thrombotic burden, driven primarily by CV\u2010RFs. Cytoreductive therapy was associated with reduced thrombotic risk, while HU exposure was linked to secondary malignancies and disease progression, probably reflecting a high disease burden in the latter. This underscores the need for refined risk stratification and long\u2010term surveillance in LR\u2010PV.\n                  <\/jats:p>","DOI":"10.1002\/hon.70200","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T16:48:49Z","timestamp":1779554929000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thrombosis in Low\u2010Risk Polycythemia Vera: Insights From a Large Real\u2010World Cohort"],"prefix":"10.1002","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3980-3305","authenticated-orcid":false,"given":"Inbar","family":"Cohen","sequence":"first","affiliation":[{"name":"Institute of Hematology Davidoff Cancer Center Rabin Medical Center  Petah Tikva Israel"},{"name":"Faculty of Medical &amp; Health Sciences Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7339-5494","authenticated-orcid":false,"given":"Alon","family":"Rozental","sequence":"additional","affiliation":[{"name":"Institute of Hematology Davidoff Cancer Center Rabin Medical Center  Petah Tikva Israel"},{"name":"Faculty of Medical &amp; Health Sciences Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[{"name":"Institute of Hematology Davidoff Cancer Center Rabin Medical Center  Petah Tikva Israel"},{"name":"Faculty of Medical &amp; Health Sciences Tel Aviv University  Tel Aviv Israel"},{"name":"Felsenstein Medical Research Center Rabin Medical Center  Petah Tikva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2035-2703","authenticated-orcid":false,"given":"Adi Shacham","family":"Abulafia","sequence":"additional","affiliation":[{"name":"Institute of Hematology Davidoff Cancer Center Rabin Medical Center  Petah Tikva Israel"},{"name":"Faculty of Medical &amp; Health Sciences Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885\u2010016\u20102208\u20102"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/m17\u20100028"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2012.42.1925"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090299"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27002"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2886"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.08.022"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096\u20108652(199709)56:1<59::aid\u2010ajh12>3.0.co;2\u2010y"},{"issue":"5","key":"e_1_2_10_10_1","first-page":"344","article-title":"Pathogenesis and Management of Bleeding in Essential Thrombocythemia and Polycythemia Vera","volume":"3","author":"Elliott M. A.","year":"2004","journal-title":"Current Hematology Reports"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.163"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201007\u2010591610"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24583"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1208500"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.07.062"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010017\u20100035\u20106"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010021\u201000581\u20106"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102006\u201008\u2010042515"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201004\u2010638593"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000211"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020232"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26423"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010024\u201001176\u20107"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003347"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24664"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010022\u201005005\u20104"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010025\u201002646\u2010y"},{"key":"e_1_2_10_28_1","unstructured":"Healthcare Funds Membership Israel 2020(2021) www.btl.gov.il."},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010022\u201004963\u2010z"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2886"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010022\u201000625\u20105"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2022.01.011"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1055\/a\u20102239\u20109265"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022418"},{"key":"e_1_2_10_35_1","unstructured":"\u201cNCCN Guidelines \u201d [Internet] https:\/\/www.nccn.org\/guidelines\/guidelines\u2010detail?category=1&id=1477."},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2018.78.8414"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010017\u20100038\u20103"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1071492"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16978"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.70200","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hon.70200","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.70200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:56:22Z","timestamp":1780307782000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.70200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/hon.70200"],"URL":"https:\/\/doi.org\/10.1002\/hon.70200","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2026-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70200"}}